4D Pharma PLC — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$718.0K

Net Income/Loss (FY2021)

-$31.9M

Total Assets (FY2021)

$58.8M

Total Equity (FY2021)

$32.4M

Cash Flows from Operating Activities (FY2021)

-$37.9M

Source: 4D Pharma PLC 20-F filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.